Since the expression of VCAM-1 was increased in CECs after stroke, a VCAM-1-based RNA aptamer was recently obtained, and an effective aptamer-based delivery platform to target CECs was constructed to treat cerebral ischemia (Franx et al., 2021; Chauveau et al., 2007). This evidence concerns the gene VCAM1 and Stroke.